title: An Official American Thoracic Society Research Statement: Impact of Mild Obstructive Sleep Apnea in Adults.
abstract: Mild obstructive sleep apnea (OSA) is a highly prevalent disorder in adults; however, whether mild OSA has significant neurocognitive and cardiovascular complications is uncertain.
  
  
  
  The specific goals of this Research Statement are to appraise the evidence regarding whether long-term adverse neurocognitive and cardiovascular outcomes are attributable to mild OSA in adults, evaluate whether or not treatment of mild OSA is effective at preventing or reducing these adverse neurocognitive and cardiovascular outcomes, delineate the key research gaps, and provide direction for future research agendas.
  
  
  
  Literature searches from multiple reference databases were performed using medical subject headings and text words for OSA in adults as well as by hand searches. Pragmatic systematic reviews of the relevant body of evidence were performed.
  
  
  
  Studies were incongruent in their definitions of "mild" OSA. Data were inconsistent regarding the relationship between mild OSA and daytime sleepiness. However, treatment of mild OSA may improve sleepiness in patients who are sleepy at baseline and improve quality of life. There is limited or inconsistent evidence pertaining to the impact of therapy of mild OSA on neurocognition, mood, vehicle accidents, cardiovascular events, stroke, and arrhythmias.
  
  
  
  There is evidence that treatment of mild OSA in individuals who demonstrate subjective sleepiness may be beneficial. Treatment may also improve quality of life. Future research agendas should focus on clarifying the effect of mild OSA and impact of effective treatment on other neurocognitive and cardiovascular endpoints as detailed in the document.
authors.forename: Susmita
authors.identifier: 0000-0002-5927-1169
authors.initials: S
authors.lastname: Chowdhuri
authors.forename: Stuart F
authors.identifier: 0000-0002-9474-7679
authors.initials: SF
authors.lastname: Quan
authors.forename: Fernanda
authors.identifier: 0000-0002-8704-9506
authors.initials: F
authors.lastname: Almeida
authors.forename: Indu
authors.initials: I
authors.lastname: Ayappa
authors.forename: Salma
authors.initials: S
authors.lastname: Batool-Anwar
authors.forename: Rohit
authors.initials: R
authors.lastname: Budhiraja
authors.forename: Peggy E
authors.initials: PE
authors.lastname: Cruse
authors.forename: Luciano F
authors.initials: LF
authors.lastname: Drager
authors.forename: Barbara
authors.initials: B
authors.lastname: Griss
authors.forename: Nathaniel
authors.identifier: 0000-0002-9014-1397
authors.initials: N
authors.lastname: Marshall
authors.forename: Sanjay R
authors.identifier: 0000-0002-9142-5172
authors.initials: SR
authors.lastname: Patel
authors.forename: Susheel
authors.initials: S
authors.lastname: Patil
authors.forename: Shandra L
authors.identifier: 0000-0002-4404-3833
authors.initials: SL
authors.lastname: Knight
authors.forename: James A
authors.initials: JA
authors.lastname: Rowley
authors.forename: Alison
authors.initials: A
authors.lastname: Slyman
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D019965:Neurocognitive Disorders / Q000150:complications* / Q000503:physiopathology; D020181:Sleep Apnea, Obstructive / Q000150:complications* / Q000503:physiopathology*; D012952:Societies; D016896:Treatment Outcome; D014481:United States